Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$6.70 USD
-0.02 (-0.30%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $6.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 37% (93 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.25 | 1.35 | 9.99 |
Current Quarter Estimate | -1.27 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -3.10 | 0.12 | 54.84 |
Next Quarter Estimate | -1.17 | 7.81 | 63.00 |
Next Year Estimate | -5.18 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 52.59 | 16.70 | 15.67 |
Next Year | 5.82 | 9.60 | 11.34 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.76 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -22.37% |
Return on Equity (TTM) | -90.38% | -31.10% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.